Dan MacLeod, Ph.D.
Dan is currently leading a group in Precision’s Cell Therapy R&D Team focused on using our ARCUS technology to engineer human T cells for cancer therapy. Prior to joining Precision, Dan was Investigator at GlaxoSmithKline working on immunomodulatory drug discovery. He performed his postdoctoral work at the International AIDS Vaccine Initiative Neutralizing Antibody Center at the Scripps Research Institute, and at the University of California, San Diego. Originally from the small town of Acme, Alberta, Canada, Dan came to the United States to further his education in a place where his poor hockey skills might go unnoticed. Dan received a B.A. from Northwestern University with a double major in Biochemistry and Psychology, and a Ph.D. in Molecular Pathology and Biomedical Sciences from the University of California, San Diego. When Dan is not busy engineering T cells, he enjoys spending time outdoors with his wife and two sons.